Erasmus Universiteit Rotterdam
www.eur.nl
20 december 2013
Corpus uteri malignancies in the Netherlands since the 1980’s: registry-based studies of trends in incidence and outcome
D. Boll
19 december 2013
Real-world cost-effectiveness: potential & pitfalls in the context of conditional reimbursement
C.W.M. van Gils (zie interview met promovenda op pagina’s 8 en 9)
11 december 2013
Burden and chemoprevention of skin cancer L.M. Hollestein 3 december 2013 Btk in autoimmunity and leukemia: too much of a good thing?
L.P. Kil
Radboud Universiteit Nijmegen
www.ru.nl
18 december 2013 &ellipsis;